4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/BIX 01294 . trihydrochloride/AG-CR1-0150-M025/25 mg
商品详细Adipogen/BIX 01294 . trihydrochloride/AG-CR1-0150-M025/25 mg
Adipogen/BIX 01294 . trihydrochloride/AG-CR1-0150-M025/25 mg
Adipogen/BIX 01294 . trihydrochloride/AG-CR1-0150-M025/25 mg
商品编号: AG-CR1-0150-M025
品牌: Adipogen Inc
市场价: ¥4400.00
美元价: 2640.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
More Information
Product Details
Synonyms 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]4-quinazolinamine . 3HCl
Product Type Chemical
Properties
Formula C28H38N6O2 . 3HCl
MW 490.6 . 109.4
CAS 1392399-03-9 | 935693-62-2 (free base)
Purity Chemicals ≥98% (NMR, HPLC)
Appearance White to off-white solid.
Solubility Soluble in DMSO (5 mg/ml) or 100% ethanol.
Identity Determined by MS, 1H- and 13C-NMR.
InChi Key FMURUEPQXKJIPS-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep under inert gas.
Protect from light.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Selective and cell permeable G9a histone-lysine methyltransferase (HMTase) inhibitor [1].
  • Does not compete with cofactor S-adenosylmethionine [1].
  • Pluripotent stem cell inducer [2, 3].
Product References
  1. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase: S. Kubicek, et al.; Mol. Cell 25, 473 (2007)
  2. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds: Y. Shi, et al.; Cell Stem Cell 3, 568 (2008)
  3. Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach: J.R. Plews, et al.; PLoS One 5, e14397 (2010)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。